Extended Release Drugs Market

Future Market Insights

Key Insight

The extended release drugs market is projected to grow from USD 65.6 billion in 2025 to USD 186.4 billion by 2035, at a CAGR of 11.0%. Sustained release will dominate with a 58.3% market share, while hospital pharmacies will lead the distribution channel segment with a 41.7% share.

July 23, 2025

Anurag Sharma

250 Pages

Cite this Report

Extended Release Drugs Market

https://www.futuremarketinsights.com/reports/extended-release-drugs-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Pfizer
Mallinckrodt
Actavis
Janssen Pharmaceuticals
Endo Pharmaceuticals
Purdue Pharma
Lavipharm Labs
Mylan Technologies
Noven
Aveva
Watson
Impax
Ranbaxy

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Extended Release Drugs Market

Key Players

Similar Industry Reports